Devices
FDA Enforcement Discretion Policy for Pandemic Tests
FDA says it is developing a general policy for the use of enforcement discretion for unauthorized tests in public health emergencies, which will be based on “lessons learned” from both the Covid-19 and monkeypox public health emergencies. The agency acknowledged the effort during a recent Government Accountability Office (GAO)